作者: Reema K. Thalji , Joseph Paul Marino , Yun Ding
DOI:
关键词:
摘要: The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by enzyme. Specifically, compounds according Formula I: wherein R1, R2, R4, R5, R6, A, B, Y, Z, n, m are defined below, pharmaceutically-acceptable salts thereof. can be used enzyme, such as hypertension. Accordingly, further pharmaceutical compositions comprising a compound invention. still methods inhibiting conditions associated therewith using or composition